Diagnostic Advances in Cancer Research Utilizing Raman Molecular Imaging to Be Presented at USCAP

PITTSBURGH, Pa. - Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's (RMI) ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's (USCAP) 100th Annual Meeting, Feb. 26-March 4 at the Henry B. [...]

OGT Awarded ISO/IEC 17025:2005 Accreditation, Signifying Technical Expertise

Oxford, UK - Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, today announced that its Genefficiency™ and CytoSure™ array comparative genomic hybridization (aCGH) services have been accredited as meeting ISO/IEC 17025:2005 international standards by the United Kingdom Accreditation Service (UKAS). The award underlines the superior level of [...]

Luminex and Partners HealthCare Announce Collaboration Agreement

AUSTIN, Texas - Luminex Corporation (Nasdaq: LMNX) announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays. This program will enable Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) to develop novel molecular diagnostic assays based on biomarkers discovered within Partners HealthCare entities. These innovative [...]

$3.5 Million Life Technologies Grant Will Help Train, Certify Forensic Scientists at UNT Health Science Center

FORT WORTH, Texas - The Center for Human Identification at the UNT Health Science Center recently received a three-year $3.5 million grant from Life Technologies Corporation (NASDAQ: LIFE), a leader in forensic DNA testing systems, to train researchers from around the world in forensic DNA analysis techniques. This first of its kind accelerated academic certification [...]

The Institute of Cancer Research and AB SCIEX Target the Spread of Disease Revealed through Mass Spectrometry Imaging

Foster City, California - A key research area for The Institute of Cancer Research (ICR) is investigating the spread of cancer in the human body in an effort to identify new and effective treatment strategies. To help advance this research, the ICR is collaborating with scientists at AB SCIEX, a global leader in life science [...]

See the NEW Masterflex L/S Precision Variable-Speed Console Drive at PITTCON 2011

The new Masterflex® L/S® Precision Variable-Speed Console Drive features a digital display that ensures accuracy and repeatability in fluid metering applications. See this new model at the Cole-Parmer® booth at PITTCON, March 13–March 18. The Masterflex drive offers precise speed control and digital display of rpm to confirm speed setting at a glance. A reversible [...]

Affymetrix Launches NG Class(TM) Detergents for Superior Protein Analysis

SANTA CLARA, Calif. - Affymetrix, Inc. (NASDAQ:AFFX) today launched its Anatrace(R) brand Neopentyl Glycol (NG) Class(TM) Detergents, the next generation of detergents to significantly advance the study of integral membrane proteins (IMPs), the most important proteins found in the human genome. Developed by leading chemists, and available only from Affymetrix, the NG Class represents a [...]

PerkinElmer Acquires chemagen Biopolymer-Technologie AG

WALTHAM, MA – PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company’s strategy to advance its offerings to the molecular [...]

BioTime Announces Agreement To Acquire Glycosan BioSystems

ALAMEDA, Calif. - BioTime, Inc. (NYSE Amex:BTX), a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it has signed a definitive agreement to merge Utah-based Glycosan BioSystems, Inc. (Glycosan) with BioTime’s wholly-owned subsidiary, OrthoCyte Corporation. The acquisition is expected to close by March 18, 2011. [...]

Shimadzu’s New TOC-L Series Provides High-Precision Analysis of Organic Compounds in Water Samples

COLUMBIA, Md. - Shimadzu Scientific Instruments introduces the TOC-L Series of analyzers for total organic carbon testing in aqueous samples. With a wide sample range from 4 ?g/L to 30,000 mg/L, the TOC-L is suitable for analyzing ultra-pure to highly contaminated samples of wastewater, brine water, seawater, drinking water and pharmaceutical water. Consisting of four [...]

Access IBO on Knowledge Center